This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Neurology  • Neurocutaneous Diseases  • Dermatologic Disorders  • Screening  • Dermatologic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Marga Lammert, MD; Jan M. Friedman, MD; Lan Kluwe, PhD; Victor F. Mautner, MD

Arch Dermatol. 2005;141:71-74.

Objective  To determine the prevalence of neurofibromatosis 1 (NF1) among 6-year-old children in Germany.

Setting and Patients  A total of 152819 children aged 6 years in 6 German states were screened for NF1 during routine medical examinations at elementary school enrollment in cooperation with local health departments in 2000 and 2001.

Main Outcome Measure  The prevalence of NF1 among 6-year-old German children was estimated to be 1:2996 (95% confidence interval, 1:2260 to 1:3984).

Results  Fifty-one NF1 cases were identified and confirmed by evaluation by appropriate medical specialists. Seven other children were found to have multiple café au lait spots without other apparent features of NF1. A minimum estimate of the crude prevalence was 3.0 per 10 000 (95% confidence interval, 2.3-4.0 per 10 000 population). The incidence of NF1 in this population was probably in the range of 30 to 38 cases per 100 000 live births.

Conclusion  Our study obtained a nearly unbiased birth incidence of NF1 of approximately 1 in 2600 to 1 in 3000 and demonstrates that NF1 can be diagnosed by age 6 years in most cases by routine physical examination with special attention to the disease-associated skin stigmata.

Author Affiliations: Department of Maxillofacial Surgery, University Hospital Eppendorf, Hamburg, Germany (Drs Lammert, Kluwe, and Mautner); and Department of Medical Genetics, University of British Columbia, Vancouver (Dr Friedman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Screening School-aged Children for Neurofibromatosis 1: Dermatology or Economics and Public Policy?
Vincent M. Riccardi
Arch Dermatol. 2005;141(1):78-79.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical and Mutational Spectrum of Neurofibromatosis Type 1-like Syndrome
Messiaen et al.
JAMA 2009;302:2111-2118.
ABSTRACT | FULL TEXT  

Diagnostic and Management Considerations Posed by Multiple Cafe au Lait Spots
Riccardi
Arch Dermatol 2009;145:929-930.
FULL TEXT  

Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
Kehrer-Sawatzki and Cooper
J. Med. Genet. 2008;45:622-631.
ABSTRACT | FULL TEXT  

Value of PET in the Assessment of Patients with Neurofibromatosis Type 1
Bredella et al.
Am. J. Roentgenol. 2007;189:928-935.
ABSTRACT | FULL TEXT  

NF1 Gene Expression in Mouse Fracture Healing and in Experimental Rat Pseudarthrosis
Kuorilehto et al.
J. Histochem. Cytochem. 2006;54:363-370.
ABSTRACT | FULL TEXT  

Screening School-aged Children for Neurofibromatosis 1: Dermatology or Economics and Public Policy?
Riccardi
Arch Dermatol 2005;141:78-79.
FULL TEXT